SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. (KOSDAQ:A246960) from Lee, Moon Soo for KRW 21.8 billion on November 18, 2022. The offer per share is KRW 17,500. Transaction is expected to be closed on December 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,770 KRW | -0.57% | +0.46% | -1.13% |
1st Jan change | Capi. | |
---|---|---|
-1.13% | 46.68M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.92% | 32.81B | |
+52.09% | 25B | |
-16.51% | 15.29B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+5.09% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- A246960 Stock
- News SCL Science Inc.
- SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo for KRW 21.8 billion.